mtmdphd Profile Banner
Mike Thompson, MD, PhD, FASCO Profile
Mike Thompson, MD, PhD, FASCO

@mtmdphd

Followers
23K
Following
140K
Media
17K
Statuses
144K

#MedSky - VP Clinical Partnerships @TempusAI #PrecisionMedicine #mmsm #lymsm #CCC19 @COVID19nCCC @ASCO COI: https://t.co/A6GQmWYvau

Milwaukee, WI
Joined September 2010
Don't wanna be here? Send us removal request.
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
1 month
Myeloma / Plasma Cell Dyscrasia ~ #ASCO25Top10 (or so) #mmsm #mmMRD #ASCO25 - @mtmdphd.- Update: 6/3/25 - cc @grpetersen1 - @HadidiSamer @AuclairDan @RahulBanerjeeMD @myelomaMD @bdermanmd @szusmani
Tweet media one
0
6
23
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
1 day
Conservation of cyclodiene insecticide resistance-associated mutations in insects [Nov 1993] @mtmdphd Steichen ffrench-Constant Insect Molecular Biology
0
0
3
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
1 day
Cloning & sequencing cyclodiene insecticide res gene from yellow fever mosquito Aedes aegypti [1993] @mtmdphd et al.
0
0
2
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
1 day
RT @MosquitoProgram: Here's a mind-blowing fact: 3,500+ mosquito species exist, but Aedes aegypti is the PRIMARY vector spreading most #den….
0
15
0
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
2 days
RT @fredhutch: Congratulations to @PGrivasMDPhD on receiving the 2025 Young Investigator Award from @eaonc! He's recognized for a distingui….
0
17
0
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
3 days
Organizing Online Health Content: Developing Hashtag Collections for Healthier Internet-Based People and Communities [Jun 28, 2019] @subatomicdoc et al. @JCOCCI_ASCO #ayacsm #bcsm #btsm #gyncsm #lcsm #mmsm #pancsm
Tweet media one
1
0
4
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
3 days
Organizing Online Health Content: Developing Hashtag Collections. [6/28/19] - @subatomicdoc @pfanderson @mtmdphd @TheLizArmy @JFreemanDaily @audvin @drdonsdizon @CBlotner_ @DavidCookeMD @womenofteal @stales @fischmd @colleen_young @DrAttai @JCOCCI_ASCO
Tweet media one
0
3
4
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
4 days
#pancsm #PrecisionMedicine.
@MarioBalsaMD
Mario Balsa
@MarioBalsaMD
4 days
🧬 Precision medicine in #PDAC moving forward #ESMOGI25: . 🎯 Actionable targets: MSI-H, TMB-H, NTRK1/3, RET, NRG1.▪️ KRAS remains king, but BRCA1/2, PALB2 & others join the map. 🧭 RNA-based NGS & molecular boards = not optional anymore. Complexity demands precision. But don’t
Tweet media one
0
0
1
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
4 days
Clinical Utility of Tumor Next-Generation Sequencing Panel Testing to Inform Treatment Decisions for Patients With Advanced Solid Tumors in a Tertiary Care Center [Jun 27, 2024] Bogdan et al. @JCOPO_ASCO #PrecisionMedicine #openaccess
Tweet media one
Tweet media two
0
1
3
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
4 days
Systematic review and meta-analysis of molecular tumor board data on clinical effectiveness and evaluation gaps [Apr 2, 2025] Gladstone et al. @Nature_NPJ Precision Oncology #PrecisionMedicine HT @bmassutis
Tweet media one
0
0
3
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
4 days
Utilization and timing of first tumor next-generation sequencing testing (NGS) in Pts w/ 5 most common cancers in the USA - @chadihcmd.et al. @huntsmancancer #ASCO25 Abstract 11014 #PrecisionMedicine #hemonc #bcsm #crcsm #lcsm #pancsm #pcsm
Tweet media one
0
1
4
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
4 days
RT @HemOncToday: The majority of patients with the most common advanced or metastatic #cancers in the United States do not undergo next-gen….
0
3
0
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
4 days
RT @TargetedOnc: BREAKING: The #FDA has granted accelerated approval to linvoseltamab for treating relapsed/refractory multiple myeloma who….
0
6
0
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
5 days
Nucleophosmin (NPM1) genomic alterations (GA) in acute myeloid leukemia (AML): A genomic landscape study - Batayneh et al. #ASCO25 Abstract 6528.#AMLsm #cagenome.
1
0
2
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
5 days
RT @JoshuaRichterMD: Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for Treatment of Relapsed or Refractory Multiple Mye….
0
13
0
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
5 days
#mmsm #caxtx @FDAOncology.
@CheckOrphan
Rare Diseases
@CheckOrphan
5 days
Lynozyfic™ (linvoseltamab-gcpt) Receives FDA Accelerated Approval for the Treatment of Relapsed or Refractory Multiple Myeloma - For More Information Visit @Regeneron #Rare_Diseases #FDA #MM #Multiple_Myeloma #OrphanDrugs #Drug_Research
Tweet media one
0
0
0
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
5 days
RT @ASH_hematology: From cuts to Medicaid to the elimination of the CDC’s Division of Blood Disorders, patients with blood diseases are fac….
0
9
0
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
5 days
RT @ASCO: Applications for @ConquerCancerFd grants and awards are officially open! Funding is available for researchers at every career sta….
0
17
0
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
5 days
RT @ASCO: Check it out! 👀.
0
1
0
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
5 days
RT @ASCO: Connect w/ peers who share your interest in building leadership skills & participate in what could be, as @montypal considers it,….
0
17
0
@mtmdphd
Mike Thompson, MD, PhD, FASCO
@mtmdphd
5 days
RT @JAMA_current: In people with HIV, HepB-CpG vaccine achieved durable seroprotection in people with prior vaccine nonresponse. https://….
0
2
0